Anitrazafen
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H17N3O2 |
Molar mass | 307.353 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Anitrazifen is a drug displaying COX-2 inhibitor activity.
Prostanoid signaling modulators | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor (ligands) |
| ||||||||||||||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||||||||||||||
Others |
| ||||||||||||||||||||||||||
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.